What happened to Tech on Friday$AMD, $STM, $NVDA, $SHOP all took a hit?
Articles
- Most Relevant
- Most Recent
This is from Irregular Lee Salisbury: I subscribe to Mampilly’s Profit Unlimited which recommends the likes of IBM, MSFT, QRVO, STM, TER, ADSK, PYPL, etc., etc. Because I’ve found Mampilly’s service reputable I listened to his newest pitch costing a mere $2995/yr, no trials, all sales final. I didn’t buy it but have to say […]
with a return of over 200,000 a year. It sounds like he’s giving recommendation a month. I’m still waiting for STM to takeoff.
I’ve been putting out my updated thoughts on each of our Irregulars spreadsheet companies (mostly past “Idea of the Month” stocks) over the last couple weeks, and now that I’m done looking at all of the “Speculations” on that list I thought I should combine them into one document to make it a bit easier […]
Pitched by Agora – Robert Burke and Louis Basenese – is this real or a stand up comedy routine. Smart Dust. An invisible network of data collection sensors …typically deployed in large swarms. They say CNN reports no one’s privacy will be secure anymore. A trillion of them by 2020. Smart Dust will transform our […]
There have been more than a few ads that talk about the “end of OPEC” — from the “Eagle Diesel” pitches made by Frank Curzio for the natural gas-driven transportation revolution, to the more misguided love affairs with geothermal energy in years past, but this one is a bit different … and, for a change, […]
We’re now a month past the “bottom” that the market hit on March 23 in the heat of the panic, and although the world is thinking about opening up now and throwing ever more “rescue” money from helicopters, we’re still not all that close to predicting when “back to normal” might hit… and just now […]
Some more stocks from our list of speculative ideas to run through today, let’s jump right in with a look at Ligand Pharmaceuticals (LGND) and Invensense (INVN), two of the faster-growing stocks I’ve covered that are seeing rapid change, and do a quick check-in on some other tech-related stocks in our speculation list that haven’t […]
Here’s your assigned reading for the week: Go check out Stop the financial pornography! from Nick Maggiulli. A good reminder of how manipulated we all can be by attention-getting investment and economic news that doesn’t really have any relevance. Don’t worry, it’s short. So… what’s up this week? Leading the news for me, outside of […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for our Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Visit his Stock Gumshoe page for more.] Bacteria are prokaryotes. Animal cells, fungi and plants are eukaryotes. Prokaryotes tend to be acellular and […]
This one already has a little discussion going among some of our intrepid Gumshoe Irregulars, and at least one of them has ID’d the right stock … but I’ve been asked to weigh in, so I’ll give it the full treatment today. The ad is for Michael Robinson’s Radical Technology Profits, which comes from Money […]
A commenter noted that Sosnowski has a new pick out that I haven’t yet seen the teaser ads for — I’ll copy the comments here: “Sosnowski has a new teaser – a niche tech company: ‘For example, recently I offered a recommendation on a company that makes a specific $2 part for the Apple iPhone […]
[Ed. Note: Myron Martin is a longtime reader who writes for the Irregulars a couple times a month about junior miners and other stocks that strike his fancy. Below is his latest contribution. As always, he’s agreed to our trading restrictions and his words and opinions are his own.] Happy Anniversary Gumshoers! Hard to believe, […]
This article was originally published on Halloween, 2018, but we’re getting a ton of new questions about it so they must be running the ad heavily again. The ad has NOT been updated in any meaningful way, but some significant things have changed for this stock over the past year (though the stock price is […]
This teaser solution first appeared as part of a Friday File that was sent to the Irregulars on January 15, 2016, so it just passed its first birthday… but so many readers are asking about it again now that we’re re-posting it for everyone to read. What follows has not been updated or revised since […]
We will no longer be publishing the commentary of Dr. KSS, who wrote about biotech stocks for the Irregulars for several years. Late last week, he decided to move on and resign from his work here. I imagine he will likely start his own publication of some sort in the future — all I know […]
Paul Mampilly is out with a teaser pitch for his Profits Unlimited newsletter from Banyan Hill, which is the entry-level ($97/yr) stock picking letter for that publisher (which used to be called the Sovereign Society). I first covered this for the Irregulars last summer, but we’re still getting a lot of questions so we opened […]
Relatively new letter in 2016, priced as an entry level letter, with goal to “get in on the ground floor in innovative companies that are just about to see explosive growth.” Mampilly previously worked on letters for Palm Beach, Stansberry and Agora Financial over the past four years. Banyan Hill (the publisher) used to be […]
[Ed. Note: Dr. KSS writes about medicine biotech stocks for the Gumshoe Irregulars. He chooses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page for his past articles and most recent comments.] Assessing biotechnology stocks involves use of lots of mental microscopes and magnifying lenses. But the task […]
Yep, another gold stock. The gold fear is leaving the markets at least a little bit now that the price has flattened out a bit in the $1,200-1,400 range over the last several months, and I expect it won’t be too long before the teaser stock mania picks up again for the miners. Today we’ve […]
Have a question in mind that you think is so dumb you’re embarrassed to ask it? That’s what we’re here for today! This bonus post was inspired by a reader who wanted to know “where to ask a dumb question” here on Stock Gumshoe… and while his question was not actually stupid, and I’m happy […]
STM has steadily grown and in the mix with Apple’s new phone and with being a large part of the Lot internet to come. I also believe they will be part of the 5G revolution. Their Market cap has doubled in 14 months. Does anyone else see the potency and growth in this stock for […]
Sometimes we just need to take a step back. On Tuesday, we were headed into a devastating trade war, with a third of our exports to China subject to punishing tariffs (in response to the tariffs proposed on more than 10% of their exports to the US)… by mid-afternoon on Wednesday, the trade war is […]
I just realized that we blew through the 11-year anniversary of the launch of Stock Gumshoe just a few days ago… and forgot to have a party or light the fireworks or anything. Ooops. Guess I was distracted by this nutty stock market… so, “happy birthday to us!” And thank you, dearest Irregular, for making […]
The latest “ADC” pitch from Michael Robinson has generated a lot of questions from readers this week, and the ad itself seems to be pretty much a carbon copy of the one sent out back in December… so we’re just re-posting this teaser solution for you. What follows is unchanged from when it first appeared […]
Every year we resolve to do better, right? That’s the human condition — we are frail, weak, and conflicted… we are busy, irritable, and unfocused… and we want to do better. It’s no different for your friends here at Stock Gumshoe… so today, as we recover from the Ides of March, I offer up some […]
I am sick and tired of seeing this little dime with a dot on it. What stock are they all teasing.
Paul Mampilly is out with a teaser pitch for his Profits Unlimited newsletter from Banyan Hill, which is the entry-level ($97/yr) stock picking letter for that publisher (which used to be called the Sovereign Society). I first covered this for the Irregulars last summer, but we’re still getting a lot of questions so we opened […]
This piece originally appeared as part of the Friday File for the Irregulars on July 28, but has now been unlocked for everyone. The company reported quarterly results about two weeks ago that were generally well received, and has otherwise gotten more positive press and analyst upgrades over the past month, and the shares are […]
This company was initially brought to my attention by Dr. KSS and Glenn Newby sometime back in 2015, as best as I can recall. It has been one of Dr. KSS’s most highly recommended stocks, though he always urged that you do your own DD. I have owned the stock since fairly early in the […]
We will no longer be publishing the commentary of Dr. KSS, who wrote about biotech stocks for the Irregulars for several years. Late last week, he decided to move on and resign from his work here. I imagine he will likely start his own publication of some sort in the future — all I know […]
Did anyone catch the Front Line Profits Summit on the 25th? Reactions/Comments?? $1995 is a ton of money to shell out.
No, Balthasar is not a biotech company. Think fast! Aragorn, Legolas and Gimli. Athos, Porthos and Aramis. Jaclyn, Farrah and Kate. Kirk, Spock and Bones. Barry, Robin and Maurice. Shadrach, Meshach and Abednego. History and culture bestow trios upon us because threesomes keep us rapt. The Three Magi, liking the Gummune as they do, have […]
I don’t know why some of my fellow EF subscribers would want to give out picks for free. Trying to pump and dump the stock on this discussion forum is silly and will not help anyone out! I am willing to sell Paul’s EF picks individually with all his writings and updates on them for […]
Hey Travis, I received this in an email this morning and was wondering if you know the stock. Thanks! Craig Now, a promise like this would be preposterous coming from anyone else … however, when a person with Paul’s credentials comes forward, one is practically required to pay attention. After all, Paul’s $6 billion hedge […]
This micro-blog is specifically for a discussion of equities trading in Pre-Market or After-Market, Or Extremely URGENT, verifiable News relating to Global Markets. It may also include certain nuances in specific markets and sharing of information with others on their Standard Operating Procedures, as well as access to those markets. Have FUN, keep it real […]
This page is for discussion of Arch Therapeutics (ARTH).
Today I’ll start by stating the obvious: One of the great problems with being an investor is that you can’t know for sure beforehand what’s a dip and a buying opportunity, and what’s the beginning of a long-term decline or a crash. That’s what sticks in my craw about mechanical stop-loss trading, because it doesn’t […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for our Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Visit his Stock Gumshoe page for more.] Bacteria are prokaryotes. Animal cells, fungi and plants are eukaryotes. Prokaryotes tend to be acellular and […]
Dr. KSS will be live blogging from the conference in the comments below.
Recent Comments
I have both Defiance and YieldMax funds, I can't wait to dump them due to the NAV erosion [I have added a GTC order on all my funds to the…...
He has had long "unbeaten" records in his core strategy, which sounds like it is essentially just selling covered calls. That probably leads to stable returns, though I don't know…...
So I looked at the ingredients of the Celsius drinks and discovered the marketing BS, "natural flavors." It does not take the interested person long to discover (and most everyone…...
For sure. When I heard that he was starting a new venture concentrating on an under-represented sector of the market, I thought finally someone was going to get serious about…...
And is his guide to how to handle the old PBRG investments useful?...
Thanks for the Info.!!...
There is a new blood test, Galleri I think that’s it, that can detect most cancers via a methylation pathway. All cancers do this. Also Function Heath for $499 a…...
I like Teeka no matter the debacle at Legacy Research. I do look forward to his explanation but it won't change the fact that Teeka is really good at what…...
Sorry folks; I seem to be confusing TSM, STM and SMT. And, while at it miss-spelled "dubious". The "under the radar stock" that Weiss recommended is STM, not SMT, which…...
Correction! Pardon my dyslexia; Yesterday I wrote that Weiss was recommending STM as an "under the radar" stock, chiding them for characterizing "the world's biggest chip maker" as such. I…...
Great teaching and value. Opened up world of options that has become a major part of my investment strategy....
Pfizer - you can check the investment amount/stake of each of those Billionares. The only issue I saw is that Pfizer only had 7 FDA approvals last year, but that…...
Here is Stansberry Research's track record on ASLE: While ASLE went from 22 to 6 and I am down -$64K, FTAI went from 6 to 72, was never recommended by…...
Did you receive the Infinity "update" over the weekend? More cut and paste and pseudo quant talk. Nothing about miners or the original Infinity hypothesis. So far no updates on…...
I started a thread here on those two TSLY and NVDY. They have paid well but NVDY has more importantly held up and appreciated while TSLY has not. Active management…...
Not really. A month is just a month, and seasonality is not so critical for the southern half of the country, which is where DFH operates. Could become a concern,…...
When I saw that a while back that Ms. Woods was heavy in RXRX and the NVDA investment I picked up a few hundred shares under $6.500 around Thanksgiving 2023…...
I certainly get your point of view and feel the same. I still like to keep my options open so I plan to watch the presentation. If he has Burke…...
RXRX they bought shares of as part of a collaboration a year ago, the other holdings are much older -- Nano-X is a remnant of a venture investment that NVDA…...
Did we ever find out the names of the cryptos from Altucher...
Yep, I remember those stories -- that got a little traction after Fukushima again, as I recall (as an investment narrative, not as an actual business), but faded fast....
Hi Travis. Thank you for your relentless dedication to keep us informed and educated. I have a lifetime subscription to Weiss Ratings' "Disruptors & Dominators" . Below are the recommendations…...
At that point from a technology perspective the most valuable company will be Intel which has made the investment with ASML to take the lead. Intel's 20A and 18A processes…...
I've noted several comments in this forum which outline rather well the would be investment counselor reality and wanted to share my point of view for what its worth. I…...
Regarding your statement, "other senses dial up in intensity": I doubt that it's a matter of your other senses becoming "more sensitive." Instead, what you have probably done is simply…...
Yes, Tilson's #1 investment, the "would feel safe putting half my kids inheritance in" is still Berkshire Hathaway (he used to say, "kids college fund," but his kids are I…...
No one has weighed in on this post since 8/23. The war in Ukraine is still going on, and there is no end in sight. Whitney Tilson is back on…...
I used to value Fry's investment recommendations, but have not had a good run with his current portfolio. Out of 47 tickers in his portfolio, 21 are down and it…...
these are all good companies and viable investments that pay dividends to shareholders. that is the bedrock of sensible investing. please explain how that constitutes a scam...
these investments pay you year in and year out like clockwork. but if you're not smart enough to see that, lottery tickets probably are your best bet...
"I decided they’d had enough time to prove that they could build and compound per-share value, and had largely failed to do so" Doc - This business has "compounded" from…...
Dear Travis, I used to be in the "Gumshoe" business myself with very limited success. I'm glad I found for no other reason(s) than the time savings, the mountains of…...
I have owned Wheaton since early 2009 and have seen my shares rise from $4.11 (Canadian funds) to over $70. WPM is the best long-term streaming investment available today. They…...
I was in BWXT at $73 just prior to you October piece. See my comment there for my view then. Short answer is that this is the ONLY company with…...
Travis, you've reminded me of an old friend of mine and consummate investor who tried to buy Google on the day of its IPO. He wasn't successful then, but picked…...
What is a MILF in terms of a stock investment?...
These are strictly income focused etfs with a strong likelihood of NAV erosion. One must be very selective with these etfs; They are not for investors seeking total returns. However,…...
Ycharts tries to simulate the impact of dividend reinvestment, but I'm sure it's not perfect -- there may be a little compounding impact that doesn't show. Not much compounding to…...
I'm retired now and use REITs and MLPs to generate income. Every day Mr Market makes you an offer. I don't care about his schizo yo-yo behavior. When I look…...
Well apparently investorsplace is offering us any of their paid subscriptions as an exchange so to speak but none of our PB investments are really being talked about . Which…...
The paper that she looked at was retracted. Here is what the editors of the journal wrote: "Following publication, concerns were raised regarding a number of claims made in this…...
Actually, India's fatality rate is just below that of the US. No, India did not distribute ivermectin. You are probably referring to one state that supposedly did so....
Stansberry Research was teasing a $7 gold trade 3 years ago that they predicted would make all kinds of money, then went to a $6 gold trade in their promotions,…...
Could be, there will definitely be some big losers in that portfolio, particularly among the stocks that I bought in 2021 (though the most recent one is also doing poorly,…...
It appears that Mr. King has made this same pitch, with slightly changed wording, for the past two or three years. Checking back, expert crypto sleuths have come up empty…...
This is the strategy. Buy puts out of the money. Lose most of your investment. Enjoy " the sky is falling" newsletters and bizarre conspiracies...
I listened to it and it seemed a bit out there. I don't see panic and i can't figure out the investment premise here....
I just watched the Altshuler pitch. It is the company that Ray Blanco, Jim Rickards and Altshuler believe will go to 100x investment. This company is dependent on th x…...
WoW fantastic post Travis. Kudos Greatly appreciate esp the a January 2023-to-date chart for each. And NVIDIA is powering ahead almost the Apple for the new age of Intelligence .…...
Travis - your comment "It is easy to be negative, and to speak with pessimism, because that tends to make you sound smart. For whatever reason, human beings tend to…...